Patent AnalyticsExaminers
Rankings

Law firm or agent

Leason Ellis LLP (Life Sciences)

127 applicationsfiled 2011 to 2026

Allowance rate
88%
+12 pts vs the USPTO range 78% to 94%
Rejections before allowance
2.2
+0.6 vs the USPTO
Months to first action
19.2 mo
+0.6 vs the USPTO
Needed an RCE
48%
+21 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations39 apps
A61P Therapeutic activity of compounds18 apps
C07J 17 apps
C07K Peptides15 apps
C07D Heterocyclic compounds13 apps
A01K 12 apps

Art units

OPAP26 apps
163213 apps
16249 apps
16267 apps
16337 apps
16277 apps

Who they file for

Clients with the most applications

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19882830A CDK9 INHIBITOR FOR USE IN THE TREATMENT OF CANCER IN A SUBJECT HAVING AN ASXL1 MU…2026-10-06Pending00n/a
19881533SUBSTITUTED THIAZINES AS GPR65 AGONISTS2026-10-01Pending00n/a
19590153METHODS AND ENGINEERED MICROORGANISMS FOR THE PRODUCTION OF HEME BIOSYNTHETIC PATHW…2026-05-22Pending00n/a
15813448Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15975464Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15425068Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15975467Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15784059Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15321097Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15711665Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 127 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in